Increase in prevalence of infectious diseases, surge in immunization programs across the globe, rise in R&D activities, and government funding and regulatory support drive the growth of the global vaccines market. PORTLAND, Ore. , May 29, 2024 /PRNewswire/ -- Allied Market Research published a report, titled, " Vaccines Market by Technology Type (Recombinant and Conjugate Vaccines, Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, and Others), Indication (Pneumococcal Disease, Influenza, Human Papilloma Virus, Meningococcal Disease, Rotavirus, Varicella, Measles, Mumps, and Rubella, Diphtheria, Pertussis, and Tetanus (DTP), Polio, Hepatitis, and Other Indications), and End User (Pediatric, Adults, and Travelers): Global Opportunity Analysis and Industry Forecast, 2024-2035".
According to the report, the "vaccines market" was valued at $43.2 billion in 2023, and is estimated to reach $90.7 billion by 2035, growing at a CAGR of 6.
4% from 2024 to 2035. Request Sample of the Report on Vaccines Market Forecast 2035 - https://www.alliedmarketresearch.
com/request-sample/258 Prime determinants of growth Increase in prevalence of infectious diseases, surge in immunization programs across the globe, rise in research and development activities, and government funding and regulatory support are the major factors that drive the growth of the global vaccines market. However, the high cost associated with the development and implementation of vaccines restricts the market gro.
